Water vapor thermal therapy (WVTT) in symptomatic benign prostatic hyperplasia (BPH) compared to other treatments or sham procedure

Reading time approx. 1 minute
This page contains 1 evidence gap
  1. Water vapor thermal therapy (WVTT) in symptomatic benign prostatic hyperplasia (BPH) compared to other treatments or sham procedure
Population:
Men with symptomatic benign prostatic hyperplasia (BPH)
Intervention:
Water vapor thermal therapy (WVTT)
Comparison:
Another treatment than the intervention (minimal invasive surgical treatment, TUR-P, pharmacologic treatment), sham procedure
Outcomes:
Lower urinary tract symptoms, adverse events, health related quality of life (HRQoL)

What evidence is needed?

More primary research is needed.

What evidence is available?

Reliable systematic reviews that show evidence gaps:

Li M, Sztaniszláv K, Breimer L, Ahlzén R, Olsson L. Injektion av förångat sterilt vatten i prostatakörteln vid symtomatisk benign prostatahyperplasi – en systematisk översikt [Water vapor thermal ablation therapy in symptomatic benign prostatic hyperplasia – a systematic review]. Örebro: HTA-enheten Camtö; 2024. HTA-rapport 2024: 64.
More about the review.

Reliable, but not updated, systematic reviews that show evidence gaps:

None identified

Registration number:
Published:
Research conducted after publication could potentially change the nature of the evidence.
To top

Evidence gap identifies methods or practices for which no conclusive systematic review of benefits and harms has been published. Gaps in scientific evidence appear on the SBU website to help researchers and granting agencies identify areas that are in need of research or systematic review. An additional objective is to offer healthcare and social service providers a basis for setting priorities.